Scar formation after repair of the cleft palate leads to growth impairment of the upper jaw and midface. The implantation of a suitable scaffold during surgery may reduce this adverse effect. However, little is known about tissue reactions to scaffolds implanted in the oral cavity. Our goal was to analyze the tissue reactions to cross-linked type I collagen scaffolds after submucoperiosteal implantation in the palate of rats. Collagen type I scaffolds were implanted in the palate of 25 male Wistar rats. Groups of 5 rats were killed consecutively after 1, 2, 4, 8, and 16 weeks and were processed for histologic and immunohistochemical analyses. After 1 and 2 weeks, 3 rats from the sham group were also killed. On hematoxylin and eosinYstained sections, the cell density and the number of giant cells were determined. Blood vessels, inflammation, and the presence of myofibroblasts were detected by immunohistochemistry. An influx of inflammatory cells started after 1 week but had completely subsided after 8 weeks. Myofibroblasts were observed within the scaffolds only in the first 2 weeks. Angiogenesis already started after 1 week and showed a peak after 4 weeks, slowly declining afterward. The scaffolds were gradually integrated within the host tissue and only elicited a mild and transient inflammatory response. The scaffolds were biocompatible and seemed to be promising for future applications in cleft palate surgery.
A cleft palate is a frequently occurring congenital malformation. 1 Surgical closure of these clefts is indicated to overcome feeding and speech problems. However, the existing surgical procedures lead to scar formation, which impairs the growth of the maxilla and the development of the dentoalveolar complex. 2Y5 A promising approach to reduce these problems may be the implantation of a scaffold loaded with growth factors to reduce scar formation. In the last decade, tissue-engineered scaffolds have already been developed for the treatment of skin wounds. These scaffolds, loaded with growth factors, enhanced wound healing and reduced scar formation after implantation in the skin. 6, 7 Particularly, collagen is widely used to prepare these scaffolds because of its overall good biocompatibility and biodegradability in the skin. 8 The immunologic biocompatibility of collagen in the skin has been demonstrated in animal models and in humans. 9, 10 The low immunogenicity of a bovine collagen scaffold in humans is due to the high-sequence homology between bovine and human collagen. 11 In addition, the collagen used is predominantly in the native triple-helical form. 12 Porous type I collagen scaffolds implanted subcutaneously in rats were shown to be biocompatible and to allow the ingrowth of cells. 13 After implantation in the skin, the scaffolds are gradually degraded and replaced by the regenerating tissue.
14 In addition, cross-linked collagen scaffolds preserved their integrity longer than noncross-linked collagen scaffolds and showed a decreased inflammatory response, probably because of their reduced degradation. 15 The implantation of collagen alone in skin was already found to reduce scar formation in animals 16 and to decrease wound contraction in a human wound model. 17 In summary, collagen scaffolds, either with or without growth factors, seem to be promising for tissue engineering purposes in the palate or elsewhere in the oral cavity. However, it is not known whether they are suitable for intraoral applications, because the dermal and oral environments are different. In addition, differences between oral and dermal fibroblasts in vitro have been reported. 18Y20 Oral wound healing is generally reported to occur faster and to be more fetal-like, 18, 21 with less scarring than wound healing in the skin. 22, 23 In contrast, some researchers claim a delayed wound healing on the palate. 24 However, most studies on intraoral wound healing are performed on buccal or periodontal wounds. 25 Studies focused on palatal wound healing did show the formation of a rigid scar tissue tightly attached to the bone. 26 Little is known about the tissue reactions to collagen scaffolds in the oral cavity. One study in rabbits showed that the implantation of partly crosslinked atelocollagen in combination with a silicon sheet decreases scarring. 27 However, the study contained only limited histologic analyses.
The aim of our study was to evaluate the tissue reaction to cross-linked collagen type I scaffolds after submucoperiosteal implantation in the palate of rats.
MATERIALS AND METHODS

Animals
T hirty-one 5-week-old male Wistar rats (Harlan, Zeist, the Netherlands), weighing between 106 and 166 g, were used. All animals were kept under normal laboratory conditions and were fed standard rat chow and water ad libitum. The rats had been acclimatized to the animal housing facility for 1 week before the start of the experiment. The experiment was approved by the board for animal experiments of Radboud University Nijmegen.
Collagen Scaffolds
Type I collagen was purified from bovine Achilles tendon, and a chemically cross-linked scaffold was prepared. 28 Briefly, a 0.8% (w/v) type I collagen suspension in 0.5-mol/L acetic acid was shaken overnight at 4-C and homogenized on ice using a Potter-Elvehjem homogenizer. Air bubbles were removed by centrifugation at 250g for 10 minutes at 4-C. The suspension was then slowly poured into a plastic mold (10 mL per 25 cm 2 ), frozen in a bath of ethanol and solid CO 2 (j80-C), and lyophilized in a Zirbus lyophilizer (ZIRBUS Technology GmbH, Bad Grund, Germany). Scaffolds were cross-linked using 33-mmol/L 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide and 6-mmol/L N-hydroxysuccinimide in 50-mmol/L 2-morpholinoethane sulfonic acid, pH 5.0, containing 40% ethanol (20 mL per 25 cm 2 ) for 4 hours at 22-C. Scaffolds were then washed with 0.1-mol/L Na 2 HPO 4 , 1-mol/L NaCl, 2-mol/L NaCl, and MilliQ water, frozen in ethanol/CO 2 again, and lyophilized.
Surgical Procedures
The rats were anesthetized with an intraperitoneal injection of 1-mL/kg body weight of ketamine (Nimatek; Eurovet Animal Health, Bladel, the Netherlands) combined with an intraperitoneal injection of 0.25-mL/ kg body weight of xylazine (Sedamun; Eurovet Animal Health, Bladel, the Netherlands). A standardized transversal incision of 3 mm was made in the palatal mucoperiosteum at the level of the contact points between the first and second molars. The mucoperiosteum was then elevated caudally for 3 mm with a periodontal probe to create a submucoperiosteal envelope. A circular collagen scaffold with a diameter of 3 mm was placed in the envelope and a 10 Â 0-vicryl suture was used to close it. The rats were medicated postoperatively with 0.02-mg/kg body weight buprenorfine (Temgesic; Schering Plough, Brussels, Belgium) subcutaneously as an analgesic. The same procedure without placement of the scaffold was performed in the sham group.
Study Design
Groups of 5 rats were killed at 1, 2, 4, 8, and 16 weeks after implantation and were processed for histologic analyses of the wound tissue. Groups of 3 rats of the sham group (6 rats) were killed at 1 and 2 weeks after implantation.
Histologic Diagnosis
The rats were perfused using freshly prepared 4% paraformaldehyde in phosphate-buffered saline (PBS). After decapitation and removal of the skin and mandible, the heads were fixed in 4% paraformaldehyde solution for 24 hours and thereafter decalcified in 10% ethylenediaminetetraacetic acid in PBS at 4-C. Serial paraffin sections of 6 mm in size were cut in the frontal plane and stained with hematoxylin and eosin (H&E, according to Delafield). Histomorphometric analyses were performed blindly using an ocular micrometer. The number of giant cells and the total number of cells in the scaffolds were counted on 3 sections (150-mm apart) for each wound. The total number of cells in the scaffolds was counted with a microscopic grid and was expressed as the number of cells per square millimeter. At 1 and 16 weeks, the cell density in the tissues surrounding the scaffolds was also quantified. The sections were also stained with the Herovici picropolychrome stain to analyze collagen deposition in the scaffolds.
Immunohistochemistry
Paraffin sections were collected on Superfrost Plus slides (Menzel-Glä ser, Braunschweig, Germany), THE JOURNAL OF CRANIOFACIAL SURGERY / VOLUME 19, NUMBER 3 May 2008 deparaffinated, and rehydrated. Before staining, the slides were rinsed in PBS for 10 minutes. aYSmooth muscle actin staining was performed for the detection of myofibroblasts, ED-1 staining was performed to detect inflammatory cells, and collagen type IV staining was performed to detect blood vessels.
aYSmooth Muscle Actin Staining Sections were treated with 3% H 2 O 2 in methanol for 10 minutes to block endogenous peroxidase and were then rinsed in PBS. Then, the sections were preincubated in 10% normal donkey serum (Chemicon Europe, Hampshire, United Kingdom) in PBS. After preincubation, the sections were incubated with monoclonal mouse antiYaYsmooth muscle actin (Sigma Chemical Co, St Louis, MO) at a ratio of 1:6400 for 60 minutes. After washing with PBS, detection was carried out using biotinylated donkey antimouse IgG (Jackson ImmunoResearch Laboratories, Inc, West Grove, PA) at a ratio of 1:100 for 60 minutes and the avidin-biotin complex method (Vectastain ABC-Elite Kit; Vector Laboratories, Burlingame, CA). The presence of myofibroblasts was scored on a scale from 0 to 3 on 3 sections (150-mm apart) for each wound. 0: No, or only a few myofibroblasts present; 1: Groups of myofibroblasts around the scaffold, no or only a few myofibroblasts in the scaffold; 2: Groups of myofibroblasts around and in the scaffold; and 3: Myofibroblasts throughout the scaffolds and the surrounding tissues.
ED-1 Staining
The ED-1 staining was performed similar to the aYsmooth muscle actin staining, but the sections were incubated with monoclonal mouseYantiYrat ED-1 (Serotec, DPC, Breda, the Netherlands) at a ratio of 1:400 for 60 minutes. This antibody recognizes a single-chain glycoprotein of 90 to 110 kd in size that is expressed predominantly on the lysosomal membrane of myeloid cells. 29 It mainly stains macrophages and monocytes. The inflammatory response was scored on a scale from 0 to 3 on 3 sections (150-mm apart) for each wound. 
Type IV Collagen Staining
The type IV collagen staining was performed similar to the aYsmooth muscle actin staining, but the sections were incubated with rabbit antiYcollagen type IV (Euro Diagnostica BV, Arnhem, the Netherlands) at a ratio of 1:200 for 60 minutes. The number of blood vessels present in the scaffolds was quantified on 3 sections (150-mm apart) for each wound.
Statistics
All measurements were performed on triplicate sections from each wound. The cell density, the number of blood vessels, and the number of giant cells in the scaffolds were counted. The outcomes at all 5 time points were compared with a one-way analysis of variance. Significant differences were further analyzed by the Holm-Sidak method. Differences in the scores for the number of myofibroblasts and the degree of inflammation at all 5 time points were compared by a Kruskal-Wallis oneway analysis of variance on ranks. Significant differences were further analyzed by the Dunn method.
The cell densities in and outside the scaffolds at 1 and 16 weeks were compared using a paired t-test. P G 0.05 was considered significant.
RESULTS
General Histologic Findings
Normal Palatal Mucoperiosteum
The palatal bone is divided in half by the midpalatal suture ( Fig 1A) . It is covered by the palatal mucoperiosteum at the oral side. A molar is visible on each side of the palate. The nasal septum divides the nose into 2 nasal cavities, which are occupied by the nasal conchae. Below the nasal septum and just above the palatal bone lies the nasopharyngeal tube. The palatal mucoperiosteum consists of 4 layers, namely, the epithelium, the lamina propria, the submucosa, and the periosteum (Fig 1B) . The epithelium is of the orthokeratotic stratified squamous type. The lamina propria consists of 2 sublayers, namely, a papillary layer containing a relatively loose network of collagenous fibers and a deeper layer with more densely packed collagenous fibers. The submucosa contains the major arteries, veins, and nerves of the palate. The periosteum consists of 2 sublayers, namely, a fibrous layer and an osteogenic layer. A cartilaginous tissue is present in the midpalatal suture between the first molars.
Palatal Mucoperiosteum After Implantation
At 1 week after implantation, the collagen scaffolds could easily be found between the submucosa and the periosteum because of their specific fibrous structure (Fig 1C) . Some inflammatory cells were present around the scaffolds, but only a few cells had invaded them (Fig 1C) . In one sample, incorporated food particles or sawdust had disturbed the healing process, and more inflammatory cells were found (not shown). Some giant cells were present at the edges of the scaffolds. At 2 weeks after implantation, more inflammatory cells were present around the scaffolds, and more cells had invaded them (Fig 1D) . At 4 weeks after implantation, the number of giant cells in and around the scaffolds seemed to be increased (Fig 1E) . The first blood vessels had also appeared in the scaffolds. After 8 and 16 weeks, almost no inflammatory cells or giant cells were present in and around the scaffolds anymore (Fig 1F) . The collagen bundles of the scaffolds had become much thinner, and the scaffolds themselves seemed to have decreased in size. In the next sections, some histologic aspects have been quantified and, where necessary, additional (immuno)histochemical staining has been performed.
Inflammation
Inflammation was scored on a scale from 0 to 3 on ED1Ystained sections (Fig 2) . ED-1 also stains giant cells, but these were counted separately on H&EYstained sections (see later). After 1 week, inflammatory cells , 625 mm) . B, Sham rat 1 week after surgery. P indicates periosteum; SM, submucosa; LP, lamina propria; E, epithelium (bar, 200 mm). C, One week after implantation (bar, 100 mm). D, Two weeks after implantation (bar, 100 mm). E, Four weeks after implantation (bar, 100 mm). F, Sixteen weeks after implantation (bar, 100 mm). Implanted scaffolds are indicated by an asterisk, and giant cells are indicated by an arrow.
were found only at the borders of the scaffolds (Fig 2A) . After 2 and 4 weeks, inflammatory cells were observed both in and around the scaffolds (Fig 2B) . However, after 16 weeks, almost all inflammatory cells had disappeared (Fig 2C) . A significant difference was only found between both 2 and 4 weeks, with a median of 2.0, and 16 weeks, with a median of 0.3 (Fig 2D) . In the samples from the sham group, groups of inflammatory cells were present after 1 week, but 1 week later, they had The asterisk denotes a significant increase after 8 and 16 weeks compared with 1 and 2 weeks. The pound sign denotes a significant difference in the increase at 4 weeks compared to 1 week. The caret sign denotes a significant difference between the cell density inside and outside the scaffolds at 1 week after implantation. largely disappeared. The number of giant cells in the scaffolds was counted on the H&EYstained sections (Fig 1) . Their number increased significantly from a mean (SD) of 6.1 (3.8) per scaffold after 1 week to a mean (SD) of 20.9 (11.4) per scaffold after 4 weeks (Fig 3A) . After 16 weeks, the number of giant cells had significantly reduced to a mean (SD) of 4.3 (1.9) per scaffold.
Cell Density
The cell density within the scaffolds was counted on H&EYstained sections (Fig 1) . At 1 and 16 weeks, the number of cells outside the scaffolds was also counted. At 1 week after implantation, a mean (SD) of 980 (223) cells/mm 2 were present in the scaffolds. This number increased significantly until 8 weeks to a mean (SD) of (Fig 4) . Collagen deposition was shown alongside the bundles of the scaffolds at 2, 4, and 8 weeks.
Myofibroblasts aYSmooth muscle actin was found in blood vessels and in myofibroblasts (Fig 5) . There were marked differences between the different time points. After the first week, myofibroblasts were abundantly present at the borders of the scaffolds, but only a few myofibroblasts had invaded the scaffolds ( Fig  5A) . One week later, the number of myofibroblasts in the scaffolds was at its maximum. Myofibroblasts were found throughout the scaffolds (Fig 5B) . At 4 weeks, only a few myofibroblasts remained (Fig 5C) .
At later time points, no myofibroblasts were found. A significant difference was shown between the myofibroblast score after 2 weeks, with a median of 2.0, and the score after both 8 and 16 weeks (median, 0.0) ( Fig  5D) . In the sham groups, myofibroblasts were present at 1 and 2 weeks.
Vascularization
The number of newly formed blood vessels within the scaffolds was counted on sections stained for type IV collagen, which is present in all basement membranes (Fig 6) . A gradual increase in the number of blood vessels was seen until 4 weeks (Fig 6A and B) . After 4 weeks, a gradual decline was noted (Fig 6C) . At 1 week, a mean (SD) of 5.9 (2.7) blood vessels was counted in the scaffolds (Fig 6D) , which had increased to a mean (SD) of 36.2 (8.2) blood vessels after 4 weeks. After 16 weeks, the number had declined to a mean (SD) of 14.3 (4.0) blood vessels (Fig 6C) . A significant difference was found between the peak at 4 weeks and all other time points (Fig 6D) . There was also a significant difference between 1 week and both 8 and 16 weeks. Not only that the number of blood Fig 6 Blood vessels. Blood vessels were stained with an antibody against collagen type IV. Basement membranes were also stained. The number of blood vessels increased until 4 weeks after implantation. A, One week after implantation. B, Four weeks after implantation. C, Sixteen weeks after implantation. Bars, 100 mm. Scaffolds (asterisks) and blood vessels within the scaffolds (arrows) are indicated. D, Number of blood vessels within the scaffolds. The asterisk denotes significant differences between 4 weeks and all the other time points. The pound sign denotes significant differences between 8 and 16 weeks, compared to 1 week. vessels had changed over time but also that the width of the blood vessels in the scaffolds appeared to increase in time.
DISCUSSION
O ur final aim was to develop a growth factor delivery system based on collagen scaffolds, which can diminish wound contraction and scar formation after cleft palate surgery. In this first study, the tissue response to cross-linked porous collagen type I scaffolds without growth factors was evaluated after submucoperiosteal implantation in the palate of rats.
A characteristic finding in the current study was that the inflammatory response and the foreign-body reaction after implantation of the scaffolds was only mild and subsided rapidly. In contrast, the total cell density of the implanted scaffolds increased steadily until 8 weeks, indicating that further tissue ingrowth was based on fibroblasts and other noninflammatory cells. This was confirmed by the immunohistochemical staining for monocytic cells and macrophages. Pieper et al 13 used similar collagen scaffolds for subcutaneous implantation in rats. In contradiction to our results, they found higher numbers of giant cells and inflammatory cells in the first weeks after implantation. This might be caused by the generally lower levels of macrophages, neutrophils, and T-cells present in oral wounds compared to skin wounds. 30 Furthermore, oral wounds contain fewer proinflammatory factors such as transforming growth factor b 1 and interleukin 6. 23, 30, 31 However, these studies were performed on open wounds in the buccal mucosa, which differs from implantation in the palatal mucosa. A study describing the implantation of collagen without telopeptides (atelocollagen) in the palate of rabbits did not report the severity of the inflammatory response. 27 However, their histologic pictures show no marked inflammatory response up to 20 weeks after implantation. A study on the implantation of atelocollagen in the gingiva of rats also showed similar results to ours, although the authors claim that atelocollagen is less antigenic than normal collagen. 32 The number of giant cells in our study increased until 4 weeks after implantation, but after 16 weeks, almost all giant cells had disappeared, although the collagen was still present. Newly formed collagen was laid down against the fibrils of the scaffolds, indicating that the scaffolds were no longer recognized as a foreign body but were integrated within the host tissue. In palatal scar tissue in rats, collagen bundles mainly have a parallel and transversal orientation. 33, 34 Because the fibrils in our scaffolds are oriented randomly, this may finally result in a more random pattern of newly formed collagen.
Further studies on the implantation of collagen scaffolds in the palate are not available, but some authors have used other materials. Two studies on biodegradable polymers implanted in the palate of dogs lack extensive description of the inflammatory response. 35, 36 Both studies report the formation of a cellular capsule around the polymers, which points toward an extensive foreign-body reaction. Premature sequestration of the polymers also occurred. This might be caused by the local accumulation of acidic degradation products and the subsequent induction of foreignbody reactions. 37, 38 Overall, our collagen scaffolds were well detectable in the specimens up to 16 weeks after implantation. The scaffolds were lost in only 2 of 25 wounds. These scaffolds might have disappeared due to loosening of the suture. Although most scaffolds were still present at all time points, they gradually became smaller, and the collagen bundles became thinner. Fast degradation of a collagen scaffold might evoke an excessive tissue reaction, because its degradation products are chemotactic to inflammatory cells. 39Y41 Furthermore, the scaffolds need to stay in place for some time to deliver growth factors in future studies. The fact that the cross-linked scaffolds largely maintained their integrity is in agreement with a 10-week follow-up study on subcutaneous implantation in rats. 13 That study showed that cross-linking of the collagen increases scaffold stability. Other studies on the implantation of collagen with different degrees of cross-linking in the palate of rats or in skin wounds in mice also support this. 42, 43 In contrast, an intraoral study in rabbits showed that cross-linked collagen scaffolds are already largely resorbed after 10 days. 27 This was probably due to the different properties of the scaffolds used, because they consisted of a crosslinked and a nonYcross-linked collagen layer. In addition, the cross-linking was performed with ultraviolet light that generally results in a considerably lower degree of cross-linking, compared with the 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide method. 44 Vascularization is an essential process for the integration of an implant. In our experiment, it started after 1 week. Studies using injectable bovine dermal collagen in human skin showed no vascularization up to 13 weeks after implantation. 45, 46 This difference might be caused by the porous structure of our collagen scaffolds. Our findings differ from those of Pieper et al, 13 who used the same scaffolds as they describe angiogenesis mainly between 2 and 4 weeks. A faster ingrowth of blood vessels might be expected on the palate compared to the skin, because oral wound healing, in general, seems to proceed faster. 23 After 4 weeks, the number of blood vessels started to decline in our study, indicating the return to normal values.
Myofibroblasts invading the scaffolds might cause their contraction similar to open wounds. We only found a transient influx of myofibroblasts between 1 and 2 weeks, including those of the sham groups, which is in accordance with a study on collagen scaffolds implanted in the palate of dogs. 47 Myofibroblasts are related to both wound contraction and scar formation. 48, 49 In palatal wounds of rats, myofibroblasts are mainly present between 4 and 22 days, with a peak intensity after 1 week. 33 On purely morphologic grounds, Dabelsteen and Kremenak 50 described the presence of myofibroblasts in open palatal wounds in dogs between 1 and 2 weeks. Also, in skin wounds, myofibroblasts are abundantly present up to 2 weeks after wounding. 51, 52 In general, a comparable influx of myofibroblasts is found in studies on open wounds and on implanted collagen scaffolds. However, a collagen scaffold might induce a more random orientation of myofibroblasts, and thus a more random pattern of newly formed collagen fibers.
In conclusion, our study shows that cross-linked collagen scaffolds are highly biocompatible after submucoperiosteal implantation. The scaffolds elicited only a mild and transient inflammatory response. They were gradually integrated within the host tissue, whereas the structure of the scaffolds remained stable for at least 16 weeks. The scaffolds seem to guide the newly formed collagen into a more random organization. The next step is to further inhibit the differentiation of myofibroblasts and subsequent scar formation by loading the collagen scaffolds with growth factors.
